OSHA News Release - Table of Contents|
Newton, Mass., medical provider cited by US Labor Department's OSHA after
workers exposed to biohazards; inspection finds willful, serious violations
New England Hematology/Oncology Associates faces nearly $47,000 in proposed fines
ANDOVER, Mass. – New England Hematology/Oncology Associates PC, a medical service provider in Newton, has been cited by the U.S. Department of Labor's Occupational Safety and Health Administration for an alleged willful and an alleged serious violation of workplace safety standards after an OSHA inspection revealed that workers were being exposed to biohazards. Proposed penalties total $46,900.
OSHA's Andover Area Office initiated the inspection in April in response to complaints by medical workers that the needles used to treat cancer patients were not safety-engineered devices and that, in removing the needles, workers were at risk of needlestick injuries. OSHA found that the workers were potentially exposed to bloodborne pathogens from needlesticks because safer needle systems, such as automatically sheathing needles, were not used.
OSHA also found that the medical provider had been made aware by workers that a safer needle system was needed but continued to use a system that was not engineered to reduce the risk of injury. As a result, OSHA has issued a citation carrying a $42,000 fine for one willful violation. A willful violation is one committed with intentional knowing or voluntary disregard for the law's requirements, or with plain indifference to worker safety and health.
"The willful violation exists because the employer initially agreed to address the issue, as required by the regulation, but did not follow through," said Jeffrey Erskine, OSHA's area director in Andover. "This medical provider put workers at risk of coming into contact with needlestick injuries because it failed to use the safest technology available to them."
OSHA also has issued a citation with a $4,900 fine for one serious violation that involves failing to review and update an exposure control plan; document the evaluation and implementation of appropriate, commercially available and effective medical devices designed to minimize occupational bloodborne pathogen exposure; and document employees' hepatitis B vaccination status. A serious violation occurs when there is substantial probability that death or serious physical harm could result from a hazard about which the employer knew or should have known.
Detailed information about bloodborne pathogen hazards and needlestick prevention is available online at http://www.osha.gov/SLTC/bloodbornepathogens/index.html.
The employer has 15 business days from receipt of the citations and proposed penalties to comply, meet informally with OSHA's area director or contest the findings before the independent Occupational Safety and Health Review Commission.
To ask questions, obtain compliance assistance, file a complaint or report workplace hospitalizations, fatalities or situations posing imminent danger to workers, the public should call OSHA's toll-free hotline at 800-321-OSHA (6742) or the agency's Andover office at 978-837-4460.
Under the Occupational Safety and Health Act of 1970, employers are responsible for providing safe and healthful workplaces for their employees. OSHA's role is to ensure these conditions for America's working men and women by setting and enforcing standards, and providing training, education and assistance. For more information, visit http://www.osha.gov.
# # #
U.S. Department of Labor news materials are accessible at http://www.dol.gov. The information above is available in large print, Braille or CD from the COAST office upon request by calling 202-693-7828 or TTY 202-693-7755.
|OSHA News Release - Table of Contents|
The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.